Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06141135 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial

Study acronym: GETSET
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 26, 2025 (before its estimated November 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Nov 15, 2024 to Nov 15, 2025
    • Study completion date: Nov 15, 2025 to Nov 15, 2026
    • Eligibility criteria revised
    • Site contact updated
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Trial Details
NCT Number NCT06141135
Lead Sponsor Genomic Prediction Inc.
Collaborators: Boston IVF
Conditions
(from sponsor)		 Infertility, Female
Related terms Infertility, Female
Enrollment 240 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov